Literature DB >> 14742985

Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects.

Takeshi Asano1, Kenji A Takahashi, Mikihiro Fujioka, Shigehiro Inoue, Keiichiro Ueshima, Tetsurou Hirata, Masahiko Okamoto, Yoshiko Satomi, Hoyoku Nishino, Takashi Tanaka, Yoshio Hirota, Toshikazu Kubo.   

Abstract

BACKGROUND: Nontraumatic osteonecrosis of the femoral head (ONFH) is one of the complications that may occur after renal transplantation. We investigated the relationship between the incidence of ONFH and polymorphisms in the genes for plasminogen activator inhibitor (PAI)-1, which is one of the major regulatory proteins of the fibrinolytic system, and 5,10-methylenetetrahydrofolate reductase (MTHFR), which is associated with the plasma levels of homocysteine in Japanese subjects.
METHODS: Thirty-one patients with postrenal transplant ONFH and 106 patients without ONFH were selected. Genotypes of PAI-1 4G/5G and MTHFR C677T were determined by direct sequencing of genomic DNA. In addition, plasma PAI-1 antigen (Ag) levels and plasma total homocysteine (tHcy) levels at the steady state were measured. The relationships between the incidence of ONFH and these genotypes, as well as plasma levels of the gene products, were investigated.
RESULTS: Plasma PAI-1 Ag levels were the highest in patients with the 4G/4G genotype, and plasma tHcy levels were the highest in patients with TT genotypes of MTHFR C677T. However, the relationship between the incidence of ONFHH and PAI-1 4G/5G or MTHFR C677T was not observed. The relationship between the incidence of ONFH and plasma levels of PAI-1 Ag or tHcy was not observed.
CONCLUSIONS: Genotypes of PAI-1 4G/5G and MTHFR C677T or plasma concentrations of PAI-1 Ag and tHcy had no effect on the incidence of ONFH in Japanese subjects, unlike the results of studies performed in white subjects. The effect of genetic background on the pathologic conditions that developed in patients with postrenal transplant ONFH may differ according to race.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742985     DOI: 10.1097/01.TP.0000101433.99651.96

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  20 in total

1.  Association between MTHFR C677T polymorphism and osteonecrosis of the femoral head: a meta-analysis.

Authors:  Xi-fu Shang; Hong Su; Wei-wei Chang; Chen-cheng Wang; Qin Han; Zhi-wei Xu
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

Review 2.  Genetic association studies in osteonecrosis of the femoral head: mini review of the literature.

Authors:  Georgios Hadjigeorgiou; Efthimios Dardiotis; Maria Dardioti; Apostolos Karantanas; Apostolos Dimitroulias; Konstantinos Malizos
Journal:  Skeletal Radiol       Date:  2008-01       Impact factor: 2.199

3.  Osteogenic abilities of bone marrow stromal cells are not defective in patients with osteonecrosis.

Authors:  Jeong Joon Yoo; Won Seok Song; Kyung-Hoi Koo; Kang Sup Yoon; Hee Joong Kim
Journal:  Int Orthop       Date:  2008-02-19       Impact factor: 3.075

Review 4.  Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis.

Authors:  Christian Powell; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

5.  A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Deborah French; Leo H Hamilton; Leonard A Mattano; Harland N Sather; Meenakshi Devidas; James B Nachman; Mary V Relling
Journal:  Blood       Date:  2008-02-19       Impact factor: 22.113

6.  Relation between osteonecrosis of the femoral head and PAI-1 4G/5G gene polymorphism: a meta-analysis.

Authors:  Zheng Zeng; Bing Wang; Haitao Pan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 7.  Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Contributes to Osteonecrosis of the Femoral Head Susceptibility: Evidence from a Systematic Review and Meta-analysis.

Authors:  Mohammad R Sobhan; Masoud Mahdinezhad-Yazdi; Mansour Moghimi; Kazem Aghili; Mohammadali Jafari; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  Arch Bone Jt Surg       Date:  2018-11

8.  New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model.

Authors:  Mohammad Amin Kerachian; Denis Cournoyer; Edward J Harvey; Terry Y Chow; Louis R Bégin; Ayoub Nahal; Chantal Séguin
Journal:  Arthritis Res Ther       Date:  2010-06-25       Impact factor: 5.156

9.  Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head.

Authors:  Hye- Ok Kim; Chang- Hoon Cho; Yoon- Je Cho; Seong- Ho Cho; Kyung- Sik Yoon; Kang- Il Kim
Journal:  BMC Musculoskelet Disord       Date:  2011-07-14       Impact factor: 2.362

Review 10.  Osteonecrosis of the Femoral Head in Patients with Hypercoagulability-From Pathophysiology to Therapeutic Implications.

Authors:  Elena Rezus; Bogdan Ionel Tamba; Minerva Codruta Badescu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.